Hillenbrand (HI) grants 7,044 RSUs to interim CFO Megan A. Walke

Rhea-AI Filing Summary

Hillenbrand, Inc. reported an equity award to an executive officer. Interim CFO, VP, CC, & CAO Megan A. Walke received 7,044 Restricted Stock Units (RSUs) as of 12/04/2025, each representing the contingent right to receive one share of Hillenbrand common stock. These RSUs carry dividend equivalent rights that accrue on dividend record dates, so the award tracks future dividends until shares are delivered.

The RSUs are scheduled to vest in three equal installments: one-third on 12/04/2026, one-third on 12/04/2027, and one-third on 12/04/2028. Following this grant, Walke beneficially owns 4,966 shares of Hillenbrand common stock directly, separate from the RSU award.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider WALKE MEGAN A

Role Interim CFO, VP, CC, & CAO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (Deferred Stock Award 12/4/2025)	7,044	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units (Deferred Stock Award 12/4/2025) — 7,044 shares (Direct); Common Stock — 4,966 shares (Direct)

Footnotes (1)

1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. Restricted Stock Units scheduled to vest one-third on 12/4/2026, one-third on 12/4/2027, and one-third on 12/4/2028.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WALKE MEGAN A

(Last) (First) (Middle)

ONE BATESVILLE BOULEVARD

(Street)

BATESVILLE IN 47006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hillenbrand, Inc. [ HI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO, VP, CC, & CAO

3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								4,966	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Deferred Stock Award 12/4/2025)	(1)	12/04/2025		A(2)		7,044		(3)	(3)	Common Stock	7,044	$0	7,044	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

3. Restricted Stock Units scheduled to vest one-third on 12/4/2026, one-third on 12/4/2027, and one-third on 12/4/2028.

Remarks:

	/s/ Allison A. Westfall, Attorney-in-fact for Megan A. Walke	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.